Identification of RNA aptamers that internalize into HPV-16 E6/E7 transformed tonsillar epithelial cells

Virology

Volumn 446, Issue 1-2, 2013, Pages 325-333

  Gourronc, Francoise A ^a   Rockey, William M ^a   Thiel, William H ^a   Giangrande, Paloma H ^a   Klingelhutz, Aloysius J ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Aptamers; Head neck; HPV; Oropharyngeal; Papillomavirus; SELEX

Indexed keywords

APTAMER; PROTEIN E6; PROTEIN E7;

ARTICLE; CELLULAR DISTRIBUTION; COMBINATORIAL CHEMISTRY; CONTROLLED STUDY; EPITHELIUM CELL; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; INTERNALIZATION; NONHUMAN; PRIORITY JOURNAL; VIRUS ENTRY;

APTAMERS; HEAD NECK; HPV; OROPHARYNGEAL; PAPILLOMAVIRUS; SELEX;

APTAMERS, NUCLEOTIDE; CELL TRANSFORMATION, VIRAL; CELLS, CULTURED; EPITHELIAL CELLS; HUMAN PAPILLOMAVIRUS 16; HUMANS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS E7 PROTEINS; REPRESSOR PROTEINS; SELEX APTAMER TECHNIQUE;

EID: 84884564294     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2013.08.015     Document Type: Article

References (59)

1. Agrawal N., Frederick M.J., Pickering C.R., Bettegowda C., Chang K., Li R.J., Fakhry C., Xie T.X., Zhang J., Wang J., Zhang N., El-Naggar A.K., Jasser S.A., Weinstein J.N., Trevino L., Drummond J.A., Muzny D.M., Wu Y., Wood L.D., Hruban R.H., Westra W.H., Koch W.M., Califano J.A., Gibbs R.A., Sidransky D., Vogelstein B., Velculescu V.E., Papadopoulos N., Wheeler D.A., Kinzler K.W., Myers J.N. Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1. Science 2011, 333:1154-1157.
2. Al Moustafa A.E., Foulkes W.D., Benlimame N., Wong A., Yen L., Bergeron J., Batist G., Alpert L., Alaoui-Jamali M.A. E6/E7 proteins of HPV type 16 and ErbB-2 cooperate to induce neoplastic transformation of primary normal oral epithelial cells. Oncogene 2004, 23:350-358.
3. Blank M., Weinschenk T., Priemer M., Schluesener H. Systematic evolution of a DNA aptamer binding to rat brain tumor microvessels. selective targeting of endothelial regulatory protein pigpen. J. Biol. Chem. 2001, 276:16464-16468.
4. Butz K., Ristriani T., Hengstermann A., Denk C., Scheffner M., Hoppe-Seyler F. siRNA targeting of the viral E6 oncogene efficiently kills human papillomavirus-positive cancer cells. Oncogene 2003, 22:5938-5945.
5. Cerchia L., de Franciscis V Targeting cancer cells with nucleic acid aptamers. Trends Biotechnol. 2010, 28:517-525.
6. Cerchia L., Esposito C.L., Jacobs A.H., Tavitian B., de Franciscis V. Differential SELEX in human glioma cell lines. PloS One 2009, 4:e7971.
7. Cerchia L., Giangrande P.H., McNamara J.O., de Franciscis V. Cell-specific aptamers for targeted therapies. Methods Mol. Biol. 2009, 535:59-78.
8. Chaturvedi A.K., Engels E.A., Pfeiffer R.M., Hernandez B.Y., Xiao W., Kim E., Jiang B., Goodman M.T., Sibug-Saber M., Cozen W., Liu L., Lynch C.F., Wentzensen N., Jordan R.C., Altekruse S., Anderson W.F., Rosenberg P.S., Gillison M.L. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J. Clin. Oncol. 2011, 29:4294-4301.
9. Chen H.W., Medley C.D., Sefah K., Shangguan D., Tang Z., Meng L., Smith J.E., Tan W. Molecular recognition of small-cell lung cancer cells using aptamers. Chem. Med. Chem. 2008, 3:991-1001.
10. Darbro B.W., Schneider G.B., Klingelhutz A.J. Co-regulation of p16INK4a and migratory genes in culture conditions that lead to premature senescence in human keratinocytes. J. Invest. Dermatol. 2005, 125:499-509.
11. Dassie J.P., Liu X.Y., Thomas G.S., Whitaker R.M., Thiel K.W., Stockdale K.R., Meyerholz D.K., McCaffrey A.P., McNamara J.O., Giangrande P.H Systemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumors. Nat. Biotechnol. 2009, 27:839-849.
12. Dillard J.P., Spear M.E. Knowledge of human papillomavirus and perceived barriers to vaccination in a sample of US female college students. J. Am. Coll. Health 2010, 59:186-190.
13. Dua P., Kim S., Lee D.K. Nucleic acid aptamers targeting cell-surface proteins. Methods 2011, 54:215-225.
14. Duffy C.L., Phillips S.L., Klingelhutz A.J. Microarray analysis identifies differentiation associated genes regulated by HPV-16 E6. Virology 2003, 314:196-205.
15. Dyson N., Howley P.M., Munger K., Harlow E. The human papilloma virus-16 E7-oncoprotein is able to bind to the retinoblastoma gene-product. Science 1989, 243:934-937.
16. Giangrande P.H., Zhang J., Tanner A., Eckhart A.D., Rempel R.E., Andrechek E.R., Layzer J.M., Keys J.R., Hagen P.O., Nevins J.R., Koch W.J., Sullenger B.A. Distinct roles of E2F proteins in vascular smooth muscle cell proliferation and intimal hyperplasia. Proc. Natl. Acad. Sci. USA 2007, 104:12988-12993.
17. Graham J.C., Zarbl H. Use of cell-SELEX to generate DNA aptamers as molecular probes of HPV-associated cervical cancer cells. PloS One 2012, 7:e36103.
18. Hernandez L.I., Stockdale-Flenker K., Hernandez F.J., Klingelhutz A.J., McNamara J.O., Giangrande P.H. Methods for evaluating cell-specific, cell-internalizing RNA aptamers. Pharmaceuticals 2013, 6:295-319.
19. Hoover A.C., Spanos W.C., Harris G.F., Anderson M.E., Klingelhutz A.J., Lee J.H. The role of human papillomavirus 16 E6 in anchorage-independent and invasive growth of mouse tonsil epithelium. Arch. Otolaryngol. Head Neck Surg. 2007, 133:495-502.
20. Huang S.H., Perez-Ordonez B., Weinreb I., Hope A., Massey C., Waldron J.N., Kim J., Bayley A.J., Cummings B., John Cho B.C., Ringash J., Dawson L.A., Siu L.L., Chen E., Irish J., Gullane P., Hui A., Liu F.F., Shen X., Xu W., O'Sullivan B. Natural course of distant metastases following radiotherapy or chemoradiotherapy in HPV-related oropharyngeal cancer. Oral. Oncol. 2013, 49:79-85.
21. Huang Y., Eckstein F., Padilla R., Sousa R. Mechanism of ribose 2'-group discrimination by an RNA polymerase. Biochemistry 1997, 36:8231-8242.
22. James M.A., Lee J.H., Klingelhutz A.J. HPV16-E6 associated hTERT promoter acetylation is E6AP dependent, increased in later passage cells and enhanced by loss of p300. Int. J. Cancer 2006, 119:1878-1885.
23. Jiang M., Milner J. Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference. Oncogene 2002, 21:6041-6048.
24. Klingelhutz A.J., Foster S.A., McDougall J.K. Telomerase activation by the E6 gene product of human papillomavirus type 16. Nature 1996, 380:79-82.
25. Klingelhutz A.J., Roman A. Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk viruses. Virology 2012, 424:77-98.
26. Larkin M.A., Blackshields G., Brown N.P., Chenna R., McGettigan P.A., McWilliam H., Valentin F., Wallace I.M., Wilm A., Lopez R., Thompson J.D., Gibson T.J., Higgins D.G. Clustal W and clustal X version 2.0. Bioinformatics 2007, 23:2947-2948.
27. Li S., Xu H., Ding H., Huang Y., Cao X., Yang G., Li J., Xie Z., Meng Y., Li X., Zhao Q., Shen B., Shao N. Identification of an aptamer targeting hnRNP A1 by tissue slide-based SELEX. J. Pathol. 2009, 218:327-336.
28. Lupold S.E., Hicke B.J., Lin Y., Coffey D.S. Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen. Cancer Res. 2002, 62:4029-4033.
29. Mallikaratchy P., Tang Z., Kwame S., Meng L., Shangguan D., Tan W. Aptamer directly evolved from live cells recognizes membrane bound immunoglobin heavy mu chain in Burkitt's lymphoma cells. Mol. Cell Proteomics 2007, 6:2230-2238.
30. Marur S., D'Souza G., Westra W.H., Forastiere A.A. HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol. 2010, 11:781-789.
31. McNamara J.O., Andrechek E.R., Wang Y., Viles K.D., Rempel R.E., Gilboa E., Sullenger B.A., Giangrande P.H. Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras. Nat. Biotechnol. 2006, 24:1005-1015.
32. McNamara J.O., Kolonias D., Pastor F., Mittler R.S., Chen L., Giangrande P.H., Sullenger B., Gilboa E. Multivalent 4-1BB binding aptamers costimulate CD8+ T cells and inhibit tumor growth in mice. J. Clin. Invest. 2008, 118:376-386.
33. Mi J., Liu Y., Rabbani Z.N., Yang Z., Urban J.H., Sullenger B.A., Clary B.M. In vivo selection of tumor-targeting RNA motifs. Nat. Chem. Biol. 2010, 6:22-24.
34. Mi J., Zhang X., Rabbani Z.N., Liu Y., Reddy S.K., Su Z., Salahuddin F.K., Viles K., Giangrande P.H., Dewhirst M.W., Sullenger B.A., Kontos C.D., Clary B.M. RNA aptamer-targeted inhibition of NF-kappaB suppresses non-small cell lung cancer resistance to doxorubicin. Mol. Ther. 2008, 16:66-73.
35. Moody C.A., Laimins L.A. Human papillomavirus oncoproteins: pathways to transformation. Nat. Rev. Cancer 2010, 10:550-560.
36. Nicol C., Cesur O., Forrest S., Belyaeva T.A., Bunka D.H., Blair G.E., Stonehouse N.J. An RNA aptamer provides a novel approach for the induction of apoptosis by targeting the HPV16 E7 oncoprotein. PLoS One 2013, 8:e64781.
37. Pu Y., Zhu Z., Liu H., Zhang J., Liu J., Tan W. Using aptamers to visualize and capture cancer cells. Anal. Bioanal. Chem. 2010, 397:3225-3233.
38. Pyeon D., Newton M.A., Lambert P.F., den Boon J.A., Sengupta S., Marsit C.J., Woodworth C.D., Connor J.P., Haugen T.H., Smith E.M., Kelsey K.T., Turek L.P., Ahlquist P. Fundamental differences in cell cycle deregulation in human papillomavirus-positive and human papillomavirus-negative head/neck and cervical cancers. Cancer Res. 2007, 67:4605-4619.
39. Scheffner M., Werness B.A., Huibregtse J.M., Levine A.J., Howley P.M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 1990, 63:1129-1136.
40. Sefah K., Meng L., Lopez-Colon D., Jimenez E., Liu C., Tan W. DNA aptamers as molecular probes for colorectal cancer study. PLoS One 2010, 5:e14269.
41. Shamah S.M., Healy J.M., Cload S.T. Complex target SELEX. Acc. Chem. Res. 2008, 41:130-138.
42. Shangguan D., Cao Z., Meng L., Mallikaratchy P., Sefah K., Wang H., Li Y., Tan W. Cell-specific aptamer probes for membrane protein elucidation in cancer cells. J. Proteome Res. 2008, 7:2133-2139.
43. Shangguan D., Cao Z.C., Li Y., Tan W. Aptamers evolved from cultured cancer cells reveal molecular differences of cancer cells in patient samples. Clin. Chem. 2007, 53:1153-1155.
44. Shangguan D., Li Y., Tang Z., Cao Z.C., Chen H.W., Mallikaratchy P., Sefah K., Yang C.J., Tan W. Aptamers evolved from live cells as effective molecular probes for cancer study. Proc. Natl. Acad. Sci. USA 2006, 103:11838-11843.
45. Shangguan D., Tang Z., Mallikaratchy P., Xiao Z., Tan W. Optimization and modifications of aptamers selected from live cancer cell lines. ChemBioChem. 2007, 8:603-606.
46. Spanos W.C., Geiger J., Anderson M.E., Harris G.F., Bossler A.D., Smith R.B., Klingelhutz A.J., Lee J.H. Deletion of the PDZ motif of HPV16 E6 preventing immortalization and anchorage-independent growth in human tonsil epithelial cells. Head Neck 2008, 30:139-147.
47. Stransky N., Egloff A.M., Tward A.D., Kostic A.D., Cibulskis K., Sivachenko A., Kryukov G.V., Lawrence M.S., Sougnez C., McKenna A., Shefler E., Ramos A.H., Stojanov P., Carter S.L., Voet D., Cortes M.L., Auclair D., Berger M.F., Saksena G., Guiducci C., Onofrio R.C., Parkin M., Romkes M., Weissfeld J.L., Seethala R.R., Wang L., Rangel-Escareno C., Fernandez-Lopez J.C., Hidalgo-Miranda A., Melendez-Zajgla J., Winckler W., Ardlie K., Gabriel S.B., Meyerson M., Lander E.S., Getz G., Golub T.R., Garraway L.A., Grandis J.R. The mutational landscape of head and neck squamous cell carcinoma. Science 2011, 333:1157-1160.
48. Tang S., Tao M., McCoy J.P., Zheng Z.M. Short-term induction and long-term suppression of HPV16 oncogene silencing by RNA interference in cervical cancer cells. Oncogene 2006, 25:2094-2104.
49. Tang Z., Shangguan D., Wang K., Shi H., Sefah K., Mallikratchy P., Chen H.W., Li Y., Tan W. Selection of aptamers for molecular recognition and characterization of cancer cells. Anal. Chem. 2007, 79:4900-4907.
50. Thiel K.W., Giangrande P.H. Therapeutic applications of DNA and RNA aptamers. Oligonucleotides 2009, 19:209-222.
51. Thiel K.W., Hernandez L.I., Dassie J.P., Thiel W.H., Liu X., Stockdale K.R., Rothman A.M., Hernandez F.J., McNamara J.O., Giangrande P.H. Delivery of chemo-sensitizing siRNAs to HER2+-breast cancer cells using RNA aptamers. Nucleic Acids Res. 2012, 40:6319-6337.
52. Thiel W.H., Bair T., Peek A.S., Liu X., Dassie J., Stockdale K.R., Behlke M.A., Miller F.J., Giangrande P.H. Rapid identification of cell-specific, internalizing RNA aptamers with bioinformatics analyses of a cell-based aptamer selection. PLoS One 2012, 7:e43836.
53. Thiel W.H., Bair T., Wyatt Thiel K., Dassie J.P., Rockey W.M., Howell C.A., Liu X.Y., Dupuy A.J., Huang L., Owczarzy R., Behlke M.A., McNamara J.O., Giangrande P.H. Nucleotide bias observed with a short SELEX RNA aptamer library. Nucleic Acid Ther. 2011, 21:253-263.
54. Toscano-Garibay J.D., Benitez-Hess M.L., Alvarez-Salas L.M. Isolation and characterization of an RNA aptamer for the HPV-16 E7 oncoprotein. Arch. Med. Res. 2011, 42:88-96.
55. Wan F., Miao X., Quraishi I., Kennedy V., Creek K.E., Pirisi L. Gene expression changes during HPV-mediated carcinogenesis: a comparison between an in vitro cell model and cervical cancer. Int. J. Cancer 2008, 123:32-40.
56. Wan Y., Kim Y.T., Li N., Cho S.K., Bachoo R., Ellington A.D., Iqbal S.M. Surface-immobilized aptamers for cancer cell isolation and microscopic cytology. Cancer Res. 2010, 70:9371-9380.
57. Yang J., Xie S.X., Huang Y., Ling M., Liu J., Ran Y., Wang Y., Thrasher J.B., Berkland C., Li B. Prostate-targeted biodegradable nanoparticles loaded with androgen receptor silencing constructs eradicate xenograft tumors in mice. Nanomedicine 2012, 7:1297-1309.
58. Zhou J., Li H., Li S., Zaia J., Rossi J.J. Novel dual inhibitory function aptamer-siRNA delivery system for HIV-1 therapy. Mol. Ther. 2008, 16:1481-1489.
59. Zuker M. M-fold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res. 2003, 31:3406-3415.